Physician profile
Suchdeep S Bains
NPI 1639269087
$3,668.90
in general payments reported to CMS, 2019-2025
22 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,769 · 2020: $723 · 2021: $440 · 2022: $513 · 2023: $66.98 · 2024: $46.74 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $808.19 | 2019-2025 | Triclip |
| Janssen Pharmaceuticals, INC | $595.36 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $308.55 | 2019-2021 | |
| Boston Scientific Corporation | $306.79 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.63 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $201.78 | 2019-2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.98 | 2019-2024 | Lifevest |
| Amgen INC. | $171.36 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $149.20 | 2019-2022 | |
| Medtronic Vascular, INC. | $130.06 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $124.26 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $84.83 | 2019 | |
| Pfizer INC. | $74.18 | 2019 | |
| Esperion Therapeutics, INC. | $57.03 | 2021 | |
| Bardy Diagnostics, INC. | $40.12 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $37.14 | 2021 | |
| Amarin Pharma, INC. | $31.79 | 2019 | |
| Portola Pharmaceuticals, LLC | $24.51 | 2019 | |
| Paratek Pharmaceuticals, INC. | $22.63 | 2024 | Nuzyra |
| Shockwave Medical, INC | $20.61 | 2019 | |
| Astellas Pharma US INC | $16.37 | 2020 | |
| Medtronic, INC. | $15.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suchdeep Bains listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.